Trials / Completed
CompletedNCT04001426
Pilot Phase for an Acute Evaluation of a Non-Implantable Electrical Continence Device
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- FemPulse Corporation · Industry
- Sex
- Female
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this feasibility clinical investigation is to investigate a new medical device treatment for Overactive Bladder (OAB) in women.
Detailed description
The FemPulse System is a vaginal ring intended to provide mild electrical stimulation to nerves that regulate bladder function. It is believed that stimulation of these nerves may help relieve the symptoms of OAB.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | The FemPulse System | Non-invasive monitoring during activation of the FemPulse System |
Timeline
- Start date
- 2019-04-04
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2019-06-28
- Last updated
- 2021-11-04
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04001426. Inclusion in this directory is not an endorsement.